Decibel Therapeutics, Inc. Proceeds from Stock Options Exercised
Decibel Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $29.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-08-11
- Decibel Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-12-31 was $201.00K.
- Decibel Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-09-30 was $100.00K.
- Decibel Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-06-30 was $1.00K.
- Decibel Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $17.00K.
- Decibel Therapeutics, Inc. proceeds from stock options exercised for fiscal 2021 was $319.00K, a 355.71% increase from fiscal 2020.
- Decibel Therapeutics, Inc. proceeds from stock options exercised for fiscal 2020 was $70.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-06-30 | $29.00K 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $301.00K derived: sum of 2 quarters · filed 2023-03-14 | $302.00K derived: sum of 3 quarters · filed 2023-03-14 | $319.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $101.00K derived: sum of 2 quarters · filed 2022-11-09 | $118.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $18.00K 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $70.00K 10-K · filed 2022-03-18 |